Not currently recruiting at UC Irvine
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)
Summary
- Eligibility
- for people ages 22 years and up (full criteria)
- Location
- at Irvine, California and other locations
- Dates
- study startedstudy ends around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Reprieve Cardiovascular, Inc
- ID
- NCT06898515
- Phase
- Phase 3 Heart Failure Research Study
- Study Type
- Interventional
- Participants
- Expecting 400 study participants
- Last Updated